Phase II.
Key Phase II services.
Our services are highly personalized to the scope and scale you require. These are some common services we deliver to companies with Phase II assets:
Scientific communication platform to underpin all communications activities
Key Opinion Leader (KOL) mapping and engagement including Digital Sphere of Influence (DOL)
Experience maps including patient journey, practice standards and buying process
Value, pricing and access including forecasts for investors and create access-focused value proposition
Evidence generation plan to maximize future investments
Related insights.
-
Read more
How can emerging biotechs strengthen their journey to commercialization?
As emerging biotech companies prepare for launch, it’s essential to prepare to maximize their future commercial potential.
-
Read more
When and why medical expertise is needed in the emerging biotech journey
It’s never too early to engage with and start thinking about medical affairs.
-
Read more
Bridging the gap between science-driven and commercially-minded decisions in emerging biotech
Shape a strategy that will build a value story around your asset.
-
Read more
Essential advice for emerging biotech
No two emerging biotechs are the same, and your strategy should be as unique as you are. Get our top tips to realizing your full potential.
Your market-leading commercialization partner.
Leveraging our connected suite of capabilities, our experts will guide you through each pivotal moment in your asset’s lifecycle, creating tailored solutions that simplify the complex, unlock value, and enhance treatment outcomes.